Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...
The Dexcom G6 continuous monitoring system (Dexcom Inc) measures interstitial fluid glucose levels. The G6 system consists of 3 key parts: the sensor wire, a transmitter, and a display device. The ...
First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required ...